Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8162)	1/1/1999 11:55:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Of greater importance than 575 is the fact that the 1st 400 are going to dsmb for safety and efficacy. Also meningo dsmb is perhaps weeks away. Ditto that on hu1124's future. Also I think depending on circumstances of money and clinicals the company might "actually"start more than 1 new indication. This is very gutsy behavior for a company with 30 some million. Interesting. So in summary I am looking towards clinicals,money, indications. Lotsa stuff, little timeframe. Seemingly unpredictable. Volitile. Hold onto your butts. :-) All IMO, all disclaimers always apply.